Cargando…
Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion
Alterations within the renal renin angiotensin system play a pivotal role in the development and progression of cardiovascular and renal disease. Angiotensin converting enzyme 2 (ACE2) is highly expressed in renal tubules and has been shown to be renoprotective in diabetes. The protease, a disintegr...
Autores principales: | Chodavarapu, Harshita, Grobe, Nadja, Somineni, Hari K., Salem, Esam S. B., Madhu, Malav, Elased, Khalid M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639987/ https://www.ncbi.nlm.nih.gov/pubmed/23646149 http://dx.doi.org/10.1371/journal.pone.0062833 |
Ejemplares similares
-
Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice
por: Alawi, Laale F., et al.
Publicado: (2020) -
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice
por: Pedersen, Kim Brint, et al.
Publicado: (2015) -
Type 2 Diabetes Leads to Axon Initial Segment Shortening in db/db Mice
por: Yermakov, Leonid M., et al.
Publicado: (2018) -
Resistin Production from Adipose Tissue Is Decreased in db/db Obese Mice, and Is Reversed by Rosiglitazone
por: Ye, Hongying, et al.
Publicado: (2013) -
PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice
por: Sun, Ying, et al.
Publicado: (2013)